Latest: FDA Approves New Biosimilar for Oncology Treatment

Patients With Ovarian Cancer, Higher Social Vulnerability Face Delayed Treatment but Earlier Palliative Care Consultations

Higher social vulnerability in patients with ovarian cancer leads to longer treatment delays but earlier palliative care consultations, highlighting critical health disparities.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago